Definitions

1. Low-density lipoprotein is the major cholesterol carrier in the blood.
2. Low-density lipoprotein (LDL) is often called "bad" cholesterol because too much in your blood can cause heart disease.

Premature Atherosclerosis

1. Low serum levels of total and low-density lipoprotein cholesterol of colectomized subjects may decrease the risk of premature atherosclerosis.

Oxidized Low-Density Lipoprotein

1. Clinical predictors of oxidized low-density lipoprotein in patients with coronary artery d.

Reduction

1. Therefore, a marked reduction in low-density lipoprotein may suggest generalized liver toxicity and drug treatment should be discontinued.
2. Studies have shown that several vitamins and nutritional supplements may contribute to a reduction in total and low-density lipoprotein cholesterol.

Diet

1. A dietary portfolio: maximal reduction of low-density lipoprotein cholesterol with diet.

Serum

1. After cholestyramine treatment alone for 2 to 16 months, serum total and low-density lipoprotein cholesterol decreased by 20 and 28 per cent, respectively.

Associated

1. Elevated cholesterol levels, especially LDL (low-density lipoprotein) cholesterol, have been associated with increased cardiovascular disease risk.
2. Human degenerative valve disease is associated with up-regulation of low-density lipoprotein receptor-related protein 5 receptor-mediated bone formation.
3. Complete deficiency of the low-density lipoprotein receptor is associated with increased apolipoprotein B-100 production.

Humans

1. Extracts of the resin of the guggul tree (Commiphora mukul) lower LDL (low-density lipoprotein) cholesterol levels in humans.

Oxidation

1. Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in man.
2. Influence of green tea and its three major components upon low-density lipoprotein oxidation.
3. Consumption of green or black tea does not increase resistance of low-density lipoprotein to oxidation in humans.

Diabetes

1. Influence of fish oil supplementation on in vivo and in vitro oxidation resistance of low-density lipoprotein in type 2 diabetes.
2. Meal-induced oxidative stress and low-density lipoprotein oxidation in diabetes: the possible role of hyperglycemia.

Hyperlipidemia

1. However, low-density lipoprotein (LDL) responses depend on the type of hyperlipidemia (ie, simple hypercholesterolemia or combined hyperlipidemia).

Infected Cells

1. They demonstrated that HCV is actively secreted by infected cells through a Golgi-dependent mechanism, while bound to a very low-density lipoprotein.

Body Mass Index

1. The two groups were comparable for age, body mass index, total and low-density lipoprotein (LDL) cholesterol levels.

Treatment

1. The effect of probucol and vitamin E treatment on the oxidation of low-density lipoprotein and forearm vascular responses in humans.

Significant Change

1. The only significant change was a 74% drop in very low-density lipoprotein during treatment.

Human Plasma

1. Consumption of red wine with meals reduces the susceptibility of human plasma and low-density lipoprotein to lipid peroxidation.

Smooth Muscle Cells

1. The smooth muscle cells have an increased permeability to platelets and lipids, especially low-density lipoprotein (LDL) cholesterol.

Artery Wall

1. Plaque starts to build up in arteries when low-density lipoprotein, the bad blood stream fat also known as LDL, gets into the artery wall.

High Levels

1. Affected people have consistently high levels of low-density lipoprotein, which leads to premature atherosclerosis of the coronary arteries.

Patients

1. In recent years, low-density lipoprotein (LDL) apheresis has emerged as an effective method of treatment in these patients.
2. The importance of low-density lipoprotein (LDL) control in the management of patients at high risk of cardiovascular events is unquestionable.
3. Effect of plant stanol tablets on low-density lipoprotein cholesterol lowering in patients on statin drugs.

Blood

1. Hypercholesterolemia results when low-density lipoprotein receptors are unable to remove cholesterol from the blood effectively.
2. Low levels of low-density lipoprotein cholesterol and blood pressure and progression of coronary atherosclerosis.

Familial Hypercholesterolemia

1. Familial hypercholesterolemia is an autosomal-dominant inherited disorder caused by mutations in the low-density lipoprotein (LDL) receptor gene.
2. Detection of mutations and large rearrangements of the low-density lipoprotein receptor gene in Taiwanese patients with familial hypercholesterolemia.
3. Genetic heterogeneity in familial hypercholesterolemia: evidence for two different mutations affecting functions of low-density lipoprotein receptor.

Cholesterol Levels

1. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events.
2. Effect of dietary trans fatty acids on high-density and low-density lipoprotein cholesterol levels in healthy subjects.
3. Close to 40% of the patients had decreases of greater than 25% in low-density lipoprotein cholesterol levels with both drugs.

Cholesterol Level

1. Saturated fat raises your low-density lipoprotein (LDL) cholesterol level more than anything else in your diet.
2. BACKGROUND: Red yeast rice is an herbal supplement that decreases low-density lipoprotein (LDL) cholesterol level.

Homozygous Familial Hypercholesterolemia

1. Homozygous familial hypercholesterolemia is caused by loss-of-function mutations in both alleles of the low-density lipoprotein (LDL) receptor gene.

Pravastatin

1. Pravastatin reduces low-density lipoprotein (LDL) cholesterol and total cholesterol in the blood.
2. Oxidized low-density lipoprotein in children with familial hypercholesterolemia and unaffected siblings: effect of pravastatin.

Low-Density Lipoprotein Apheresis

1. Long-term safety and efficacy of low-density lipoprotein apheresis in childhood for homozygous familial hypercholesterolemia.

Apheresis

1. Anaphylactoid reactions have also been reported in patients undergoing low-density lipoprotein apheresis with dextran sulfate absorption.
2. Low-density lipoprotein apheresis for the treatment of refractory hyperlipidemia.
3. Long-term efficacy of low-density lipoprotein apheresis on coronary heart disease in familial hypercholesterolemia.

Rosuvastatin

1. Rosuvastatin is a new, synthetic, orally active statin, with marked low-density lipoprotein (LDL) cholesterol-lowering activity.

Bad

1. They also saw their low-density lipoprotein ("bad") cholesterol levels reduced by about 7 percent and their systolic blood pressure lowered by 7 mm Hg.

Lower

1. Dietary phytosterols have been reported to lower total and low-density lipoprotein (LDL) cholesterol.
2. Cocoa flavanol-enriched snack bars containing phytosterols effectively lower total and low-density lipoprotein cholesterol levels.

Levels

1. Screening for CAD includes evaluating high-density and low-density lipoprotein (cholesterol) levels and triglyceride levels.
2. Background Ezetimibe, a cholesterol-absorption inhibitor, reduces levels of low-density lipoprotein (LDL) cholesterol when added to statin treatment.
3. Prevention of restenosis after percutaneous transluminal coronary angioplasty by reducing lipoprotein (a) levels with low-density lipoprotein apheresis.

Risk

1. BACKGROUND: Both C-reactive protein and low-density lipoprotein (LDL) cholesterol levels are elevated in persons at risk for cardiovascular events.
2. Low-density lipoprotein, or LDL, known as the "bad" cholesterol, can clog arteries, increasing the risk of heart attack and stroke.
3. Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men.

Atherosclerosis

1. Atherosclerosis ("hardening of the arteries") arises from the low-density lipoprotein (LDL) form of cholesterol.
2. Free radicals can also enhance the dangerous properties of low-density lipoprotein (LDL) cholesterol, a major player in the development of atherosclerosis.
3. Low-density lipoprotein cholesterol, particularly oxidized LDL, affects atherosclerosis, endothelial function, and clinical cardiovascular outcomes.

Triglycerides

1. Lipid assessment included lipoprotein(a), total cholesterol, low-density lipoprotein, high-density lipoprotein, and triglycerides.
2. After 24 weeks, total cholesterol (TC) was decreased by 22.2%, low-density lipoprotein (LDL) cholesterol by 25.8% and triglycerides (TG) by 13.6%.
3. Statins lower levels of fatty substances such as low-density lipoprotein, or "bad" cholesterol, and triglycerides.

Ldl

1. Low-density lipoprotein (or LDL) cholesterol is a bad type of cholesterol that is most likely to clog blood vessels, increasing your risk for heart disease.
2. The researchers measured total, low-density lipoprotein (LDL), and high-density lipoprotein (HDL) cholesterol levels.
3. Serum total cholesterol, low-density lipoprotein (LDL) and triglyceride levels were not different in cases compared with control subjects.

Low-Density Lipoprotein Cholesterol

1. HFE C282Y homozygosity is associated with lower total and low-density lipoprotein cholesterol: The hemochromatosis and iron overload screening study.
2. The incidence of a major coronary event was correlated to serum TC and low-density lipoprotein cholesterol (LDL-C) levels in both groups.
3. In this group, significantly higher levels of total cholesterol, low-density lipoprotein cholesterol, and apolipoprotein B-100 were found.

Cholesterol

1. Effect of rosuvastatin on low-density lipoprotein cholesterol in patients with hypercholesterolemia.
2. High levels of low-density lipoprotein cholesterol (LDL) (hypercholesterolemia) are commonly present in the nephrotic syndrome.
3. MAIN OUTCOME MEASURES: Percentage change in levels of directly measured low-density lipoprotein cholesterol (LDL-C) after 8 weeks of therapy.

Low-Density Lipoprotein

1. One type of cholesterol is low-density lipoprotein or LDL. High levels of LDL (bad cholesterol) increase the risk of cardiovascular disease.
2. High levels of low-density lipoprotein (LDL) cholesterol, the "bad" cholesterol, may increase your risk of atherosclerosis.
3. It gives information about total cholesterol, low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol and triglycerides.

Categories

1. Drugs > Alcohol > Alcohols > Cholesterol
2. Ldl
3. Triglycerides
4. Familial Hypercholesterolemia
5. Humans > Health > Diseases > Atherosclerosis
6. Books about "Low-Density Lipoprotein" in Amazon.com
   

Continue: More Keywords - - - - - - - - - -